These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15332575)

  • 1. [Cardiorenal interactions: clinical implication and role in pathogenesis of cardiovascular and renal diseases].
    Mukhin NA; Moiseev VS; Kobalava ZhD; Moiseev SV; Fomin VV
    Ter Arkh; 2004; 76(6):39-46. PubMed ID: 15332575
    [No Abstract]   [Full Text] [Related]  

  • 2. [The renin-angiotensin system in cardiovascular pathogenesis caused renal diseases: a new recognition].
    Lin SY
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1729-31. PubMed ID: 16253154
    [No Abstract]   [Full Text] [Related]  

  • 3. The renin-angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations.
    Vargas F; Rodríguez-Gómez I; Vargas-Tendero P; Jimenez E; Montiel M
    J Endocrinol; 2012 Apr; 213(1):25-36. PubMed ID: 22043064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical risk markers: a novel area for better prediction of renal risk?
    Stuveling EM; Bakker SJ; Hillege HL; de Jong PE; Gans RO; de Zeeuw D
    Nephrol Dial Transplant; 2005 Mar; 20(3):497-508. PubMed ID: 15735241
    [No Abstract]   [Full Text] [Related]  

  • 5. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.
    Rubattu S; Sciarretta S; Valenti V; Stanzione R; Volpe M
    Am J Hypertens; 2008 Jul; 21(7):733-41. PubMed ID: 18464748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spotlight on renin: cardiovascular outcomes in chronic kidney disease and suppression of the renin-angiotensin system.
    Garcia-Donaire JA; Ruilope LM
    J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):56-8. PubMed ID: 17083074
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?
    Schrier RW
    J Am Coll Cardiol; 2006 Jan; 47(1):1-8. PubMed ID: 16386657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane biosynthesis and metabolism in cardiovascular and renal disease.
    Patrono C; Patrignani P; Daví G
    J Lipid Mediat; 1993; 6(1-3):411-5. PubMed ID: 8357999
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of the natriuretic peptide system in cardiorenal protection.
    McFarlane SI; Winer N; Sowers JR
    Arch Intern Med; 2003 Dec 8-22; 163(22):2696-704. PubMed ID: 14662623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin receptor blockers: novel role in high-risk patients.
    Javed U; Deedwania PC
    Cardiol Clin; 2008 Nov; 26(4):507-26. PubMed ID: 18929228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine in renal disease.
    Ducloux D; Motte G; Chalopin JM
    Clin Lab; 2000; 46(3-4):141-51. PubMed ID: 10791121
    [No Abstract]   [Full Text] [Related]  

  • 12. Atrial natriuretic factors: a review.
    Kruse AP
    Prog Cardiovasc Nurs; 1988; 3(2):39-44. PubMed ID: 2966961
    [No Abstract]   [Full Text] [Related]  

  • 13. [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].
    Ratto E; Leoncini G; Viazzi F; Pontremoli R
    G Ital Nefrol; 2008; 25(1):21-31. PubMed ID: 18264915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.
    Raij L
    Am J Hypertens; 2005 Apr; 18(4 Pt 2):95S-99S. PubMed ID: 15837551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of renin-angiotensin blockade in patients receiving dialysis.
    Suzuki H
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):397-405. PubMed ID: 19491138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erectile dysfunction as cardiovascular risk marker. Role of the renin-angiotensin system].
    Böhm M; Kratz MT; Schlimmer N; Baumhäkel M
    Dtsch Med Wochenschr; 2008 Jun; 133(24):1313-6. PubMed ID: 18473289
    [No Abstract]   [Full Text] [Related]  

  • 17. Slowing progression along the renal disease continuum.
    Kopyt NP
    J Am Osteopath Assoc; 2005 Apr; 105(4):207-15. PubMed ID: 15928338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic renin-angiotensin-aldosterone system in the cardiometabolic syndrome and type 2 diabetes mellitus.
    Hayden MR; Sowers JR
    J Cardiometab Syndr; 2008; 3(3):129-31. PubMed ID: 18983326
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypertension and renal disease].
    Kamper AL; Pedersen EB; Strandgaard S
    Ugeskr Laeger; 2009 Jun; 171(25):2109-13. PubMed ID: 19671393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease.
    Re RN
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):42-7. PubMed ID: 16265259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.